Plasma exchange for Guillain-Barré syndrome

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 2, 2017, Pages

  Chevret, Sylvie ^a   Hughes, Richard A C ^b   Annane, Djillali ^c  

^a SAINT LOUIS HOSPITAL   (France)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; GELATIN;

ARTIFICIAL VENTILATION; CAUSE OF DEATH; CENTRIFUGATION; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); CONVALESCENCE; COST BENEFIT ANALYSIS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; EMBASE; EVIDENCE BASED PRACTICE; FILTRATION; FOLLOW UP; GUILLAIN BARRE SYNDROME; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; LOW RISK PATIENT; LUNG EMBOLISM; MEDLINE; MUSCLE STRENGTH; NEUROLOGIC EXAMINATION; NEUROPATHY; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PLASMA EXCHANGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REVIEW; RISK FACTOR; SENSORY DYSFUNCTION; SEPARATION TECHNIQUE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TIME TO TREATMENT; TREATMENT WITHDRAWAL; WALKING; WALKING AID; GUILLAIN-BARRE SYNDROME; IMMUNOLOGY; META ANALYSIS; RECURRENT DISEASE; TREATMENT OUTCOME;

GUILLAIN-BARRE SYNDROME; HUMANS; MUSCLE STRENGTH; PLASMA EXCHANGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; RECURRENCE; TREATMENT OUTCOME;

EID: 85014121628     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001798.pub3     Document Type: Review

References (53)

1. Färkkilä M, Kinnunen E, Haapanen E, Livanainen M. Guillain Barré syndrome: quantitative measurement of plasma exchange therapy. Neurology 1987;37(5):837-40. [PUBMED: 3553986]2806929
2. Greenwood RJ, Newsom-Davis J, Hughes RAC, Aslan S, Bowden AN, Chadwick DW, et al. Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;1(8382):877-9. [PUBMED: 6143188]2806931
3. The Guillain-Barré syndrome study group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35(8):1096-104. [PUBMED: 4022342]2806933
4. Osterman PO, Fagius J, Lundemo G, Pihlstedt P, Pirskanen R, Siden A, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984;2(8415):1296-9. [PUBMED: 6150321]2806935
5. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Annals of Neurology 1987;22(6):753-61. [PUBMED: 2893583]2806937
6. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Plasma exchange in Guillain-Barré syndrome: one year follow-up. Annals of Neurology 1992;32(1):94-7. [PUBMED: 1642477]2806938
7. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré Syndrome. Annals of Neurology 1997;41(3):298-306. [PUBMED: 9066350]2806940
8. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré Syndrome. Annals of Neurology 1997;41(3):298-306. [PUBMED: 9066350]2806942
9. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré Syndrome. Annals of Neurology 1997;41(3):298-306. [PUBMED: 9066350]2806944
10. de-Zoysa NS, Jayaweera KK, Vaithianathan T. Manual plasmapheresis in the treatment of Guillain Barré syndrome. Journal of Clinical Apheresis 1994;9(2):147-50. 2806946
11. El-Bayoumi MA, El-Refaey AM, Abdelkader AM, El-Assmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré Syndrome. A randomized study. Critical Care. 2011; Vol. 15:R164. 2806948
12. Mendell JR, Kissel JT, Kennedy MS, Sahenk Z, Grinvalsky HT, Pittman GL, et al. Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomised trial. Neurology 1985;35(11):1551-5. 2806950
13. Morosetti M, Meloni C, Taccone Gallucci M, Rossini PM, Felicioni R, Palombo G, et al. Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome. ASAIO Journal 1994;40(3):M638-42. 2806952
14. Rock G. Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group. Journal of Clinical Apheresis 1997;12(4):165-9. 2806954
15. Wollinsky KH, Hulser PJ, Brinkmeier H, Aulkemeyer P, Bossenecker W, Huber-Hartmann KH, et al. CSF filtration is an effective treatment of Guillain Barré syndrome: a randomized clinical trial. Neurology 2001;57(5):774-80. 2806956
16. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Annals of Neurology 1990;27 Suppl:S21-4.
17. Bouget J, Chevret S, Chastang C, Raphael JC. Plasma exchange morbidity in Guillain Barré syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Critical Care Medicine 1993;21(5):651-8.
18. Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet 1978;2(8099):1100.
19. Consensus Conference. The utility of therapeutic plasmapheresis for neurological disorders. Journal of the American Medical Association 1986;256(10):1333-7.
20. Cook SD, Dowling PC, Murray MR, Whitaker JN. Circulating demyelinating factors in acute idiopathic polyneuropathy. Archives of Neurology 1971;24(2):136-44.
21. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011;76(3):294-300.
22. Espérou H, Jars Guincestre MC, Bolgert F, Raphael JC, Durand-Zaleski I, and the French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Cost-effectiveness of plasma exchange therapy for the treatment of Guillain-Barré syndrome. Intensive Care Medicine 2000;26(8):1094-100.
23. Farkkila M, Penttila P. Plasma exchange therapy reduces the nursing care needed in Guillain-Barré syndrome. Journal of Advanced Nursing 1992;17(6):672-5.
24. Jan Brozek, Andrew Oxman, Holger Schünemann. GRADEpro. Version 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008.
25. Harrison BM, Hansen LA, Pollard JD, Mc Leod JG. Demyelination induced by serum from patients with Guillain-Barré syndrome. Annals of Neurology 1984;15(2):163-70.
26. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978;2(8104-5):750-3.
28. Hughes RA, Swan AV, Raphael JC, Annane D, Van Koningsveld, Van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007;130(Pt 9):2245-57.
29. Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD008630.pub2]
30. Hughes RA, Swan AV, Van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD002063.pub6]
31. Mark B, Hurwitz J, Olanow CW, Fay JW. Plasmapheresis in idiopathic inflammatory polyradiculoneuropathy. Neurology 1980;30(4):361.
32. The Guillain-Barré Syndrome Study Group. The North American study of plasmapheresis in the Guillain-Barré syndrome. Journal of Clinical Apheresis 1985;2:315-20.
33. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher RS, Quaskey SA, et al. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Annals of Neurology 1988;23(4):347-53.
34. Mendell JR, Kissel JT, Kennedy MS, Sahenk Z, Grinvalsky HT, Pittman GL, et al. Plasma exchange and prednisone in acute inflammatory polyradiculoneuropathy: a controlled randomized trial. Journal of Clinical Apheresis 1985;2(4):332-42.
35. Metral S, Raphaël JC, Hort-Legrand CL, Elkharrat D. Serum demyelinating activity and Guillain-Barre syndrome: favorable effect of plasma exchange [Activité démyélinisante sérique et syndrome de Guillain-Barré: effet favorable des échanges plasmatiques]. Revue Neurologique 1989;145(4):312-9.
36. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349(9047):225-30.
37. Raphael JC, Chastang C, and the Cooperative French Group. Cooperative randomized trial of plasma exchange in Guillain-Barré syndrome. Plasma Therapy and Transfusion Technology 1985;6:603-4.
38. Raphael JC, Chastang C. Cooperative randomized trial of plasma exchange in the Guillain-Barré syndrome. Short term effects and comparison of diluted albumin and fresh frozen plasma. Life Support System 1986;4:329-31.
39. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. Annals of Neurology 1992;32(1):94-7.
40. Raphaël JC, Chevret S, Jars-Guincestre MC, Chastang C, Gajdos PH. Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy [Traitement du syndrome de Guillain-Barré par les échanges plasmatiques: proposition d'une stratégie thérapeutique]. Revue Neurologique 1996;152(5):359-64.
41. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
42. Ropper AH, Shahani B, Huggins CE. Improvement in four patients with acute Guillain-Barré syndrome after plasma exchange. Neurology 1980;30:361.
43. Schooneman F, Janot C, Streiff F, Gérard A, Dureux JB, Canton P, et al. Plasma exchange in Guillain-Barré syndrome ten cases. Plasmapheresis Therapy 1981;2:117-21.
44. Shumak KH, Rock GA. Therapeutic plasma exchange. New England Journal of Medicine 1984;310(1212):762-71.
45. Sumner A, Said G, Idy I, Metral S. Electrophysiological and morphological effects of the injection of Guillain-Barré sera in the sciatic nerve of the rat [Syndrome de Guillain-Barré. Effects electro-physiologiques du sérum humain introduit dans l'espace endoneural du nerf sciatique du rat. Résultats préliminaires]. Revue Neurologique 1982;138(1):17-24. [MEDLINE: 1982249353]
46. Valbonesi M, Garelli S, Mosconi L, Zerbi D, Celano I. Plasma exchange as a therapy for Guillain-Barré syndrome with immune complexes. Vox Sanguinis 1981;41:74-8.
47. Van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. New England Journal of Medicine 1992;326(17):1123-9.
48. Visser LH, Schmitz PI, Meulstee J, Van Doorn PA, Van der Meché FG. Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group. Neurology 1999;53(3):598-604.
49. Willison HJ, Jacobs BC, Van Doorn PA. Guillain-Barré syndrome. Lancet 2016;388:717-27.
50. Yuki N, Hartung HP. Guillain-Barré syndrome. New England Journal of Medicine 2012;366(24):2294-304.
51. Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD001798.pub2]
52. Raphaël JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD001798]
53. Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD001798]